EM

Pharmaceutical products; therapeutic drugs and agents, namely antibody-based therapies, antibodies, antibody fragments, bispecific antibodies; T-cell bispecific antibodies; pharmaceutical preparations namely antibody engineering, antibody production and purification for the treatment of hematological malignancies, solids tumors and diseases of the immune system; namely multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphomas, systemic lupus erythematosus